Bridgebio Pharma Inc (BBIO)

Capital Expenditure

-$443.00K

Quarterly · Period ending: · USD

BBIO logo

BBIO Capital Expenditure

Latest reported-$443.00K
BBIO Quarterly CapEx (-$15.18M → -$443.00K)
High-resolution chart · PNG

BBIO capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-443,000
-69,000
-4,533,000
-470,000
-5,094,000
-1,595,000
-3,237,000
-1,732,000
-2,447,000
-1,492,000
-435,000
-431,000
-428,000
-12,000
-801,000
-759,000
-3,902,000
-859,000
-2,536,000
-41,462,000
-2,287,000
-1,961,000
-2,146,000
-549,000
-346,000
-4,477,000
-1,747,000
-381,000
-583,000
-2,427,000
-741,000
-605,000
-1,655,000
-15,177,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.